HF
MYOV

HRT Financial’s Myovant Sciences Ltd. MYOV Stock Holding History

HRT Financial’s Portfolio MYOV Stock Details MYOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-73,528
Closed -$913K – 3777
2022
Q2 		$913K Buy
+73,528
New +$811K 0.01% 1019
2022
Q1 		– Sell
-48,344
Closed -$752K – 4129
2021
Q4 		$752K Buy
+48,344
New +$923K ﹤0.01% 1376
2021
Q1 		– Sell
-17,995
Closed -$497K – 3308
2020
Q4 		$497K Buy
+17,995
New +$350K 0.01% 1029

Other funds holding MYOV

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

HRT Financial's MYOV Position: Q3 2022 in Review

HRT Financial sold out of Myovant Sciences Ltd. (MYOV) in Q3 2022, closing a stake of 73,528 shares — an estimated $913K sold.

HRT Financial first reported a position in MYOV in Q4 2020 and held it in 3 quarters. The position peaked at $913K in Q2 2022. 98 funds tracked by Wall St. Rank hold MYOV as of Q3 2022.

  • HRT Financial reported no remaining Myovant Sciences Ltd. position as of Q3 2022 after selling out during the quarter.
  • HRT Financial sold 73,528 Myovant Sciences Ltd. shares in Q3 2022, an estimated $913K.
  • HRT Financial first reported a position in Myovant Sciences Ltd. in Q4 2020 and held it in 3 quarters.
  • HRT Financial's Myovant Sciences Ltd. position peaked at $913K in Q2 2022.
  • 98 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q3 2022.

Based on HRT Financial's 13F filing for Q3 2022, filed 14 Nov 2022.